Drug
VX-135 clinical trials
Also written VX-135.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2012
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
3 studies that test it; most in 2013 (2)
| Year | Studies |
|---|---|
| 2012 | 1 |
| 2013 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Vertex Pharmaceuticals Incorporated (2) · Alios Biopharma Inc. (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses VX-135 is read from its arms, and is right about nine times in ten.
Testing it · 3
- A Phase 2a, Dose-Ranging Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis CCompletedPhase 2Alios Biopharma Inc.NCT01790100Written as VX-135
- A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of VX-135 and Daclatasvir in Subjects With Genotype 1 Chronic Hepatitis C Chronic Hepatitis CCompletedPhase 2Vertex Pharmaceuticals IncorporatedNCT01842451Written as VX-135
- A Phase 2 Study to Evaluate the Safety and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis CCompletedPhase 2Vertex Pharmaceuticals IncorporatedNCT01726946Written as VX-135